{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/50090-6247#drug","name":"Biktarvy","alternateName":"bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"50090-6247"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA210251"},{"@type":"PropertyValue","propertyID":"UNII","value":"4L5MP1Y7W7|G70B4ETF4S|FWF6Q91TZO"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"0476d7eb-1024-4821-bbe7-abaacfda32a2"}],"activeIngredient":"BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE","administrationRoute":["ORAL"],"dosageForm":"TABLET","manufacturer":{"@type":"Organization","name":"A-S Medication Solutions"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA210251","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0476d7eb-1024-4821-bbe7-abaacfda32a2","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-6247"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-04T11:36:25.305Z"}}